Nianli Liu

Also affiliated with Cellular Therapeutics (United Kingdom)

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression”.

The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression

Journal of Experimental & Clinical Cancer Research(2023)10.1186/s13046-023-02844-5

N/A

0DataRank · unranked

28 citations

Jinqiang Zhang, Weina Chen, Wenbo Ma, Tong Wu, Nianli Liu

The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling

Journal of Experimental & Clinical Cancer Research(2024)10.1186/s13046-024-03036-5

N/A

0DataRank · unranked

12 citations

Jinqiang Zhang, Weina Chen, Nianli Liu, Tong Wu, Wenbo Ma

RBM39 Enhances Cholangiocarcinoma Growth Through EZH2-mediated WNT7B/β-catenin Pathway

Cellular and Molecular Gastroenterology and Hepatology(2024)10.1016/j.jcmgh.2024.101404

N/A

0DataRank · unranked

10 citations

Jinqiang Zhang, Weina Chen, Wenbo Ma, Tong Wu, Nianli Liu

Notch-Driven Cholangiocarcinogenesis Involves the Hippo Pathway Effector TAZ via METTL3-m6A-YTHDF1

Cellular and Molecular Gastroenterology and Hepatology(2024)10.1016/j.jcmgh.2024.101417

N/A

0DataRank · unranked

7 citations

Jinqiang Zhang, Weina Chen, Nianli Liu, Tong Wu, Wenbo Ma